Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/7/21 16:45 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 7,000 | 14.00 | 0 | 500 | 33 | 2,031 | I | ||||||||||||||
7/6/21 17:03 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.d | 39,000 | 14.00 | 0 | 2,786 | 311 | I | ||||||||||||||||
7/6/21 16:28 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | P.d | 5,000 | 14.00 | 0 | 357 | 10 | 3,759 | D | |||||||||||||||
7/6/21 16:27 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Katabi Maha | MA | DT | P.d | 5,000 | 14.00 | 0 | 357 | 10 | 3,759 | I | |||||||||||||||
7/6/21 16:27 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Grayzel David S. | MA | D | P.d | 7,500 | 14.00 | 0 | 536 | 21 | 3,104 | I | |||||||||||||||
7/6/21 16:26 | 7/2/21 | AVTE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xii, L.P. | MA | T | P.d | 7,500 | 14.00 | 0 | 536 | 21 | 3,104 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |